Literature DB >> 3522426

Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities.

N A Strockbine, L R Marques, J W Newland, H W Smith, R K Holmes, A D O'Brien.   

Abstract

Escherichia coli O157:H7 strain 933 contains two distinct toxin-converting phages (933J and 933W). The biologic activities and antigenic relationship between the toxins produced by 933J and 933W lysogens of E. coli K-12, as well as the homology of the genes that encode the two toxins, were examined in this study. The 933J and 933W toxins, like Shiga toxin produced by Shigella dysenteriae type 1, were cytotoxic for the same cell lines, caused paralysis and death in mice, and caused fluid accumulation in rabbit ileal segments. The cytotoxic activity of 933J toxin for HeLa cells was neutralized by anti-Shiga toxin, whereas the activity of 933W toxin was not neutralized by this antiserum. In contrast, an antiserum prepared against E. coli K-12(933W) neutralized 933W toxin but not 933J toxin or Shiga toxin. For E. coli 933, most of the cell-associated cytotoxin was neutralized by anti-Shiga toxin, whereas most of the extracellular cytotoxin was neutralized by anti-933W toxin. However, a mixture of these antisera indicated the presence of both toxins in cell lysates and culture supernatants. Among 50 elevated cytotoxin-producing strains of E. coli, we identified 11 strains isolated from cases of diarrhea, hemorrhagic colitis, or hemolytic uremic syndrome that produced cell-associated cytotoxins which were neutralized by the 933W antitoxin. Southern hybridization studies showed that the cloned toxin structural genes from phage 933J hybridized with DNA from phage 933W under conditions estimated to allow no more than 26% base-pair mismatch. These findings indicate that E. coli produces two genetically related but antigenically distinct cytotoxins with similar biologic activities which we propose to name Shiga-like toxins I and II. Strains of E. coli that produce elevated levels of Shiga-like toxin I or Shiga-like toxin II, or both, have been associated with the clinical syndromes of diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3522426      PMCID: PMC260087          DOI: 10.1128/iai.53.1.135-140.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

Review 1.  Shigella toxin(s): description and role in diarrhea and dysentery.

Authors:  G T Keusch; A Donohue-Rolfe; M Jacewicz
Journal:  Pharmacol Ther       Date:  1981       Impact factor: 12.310

2.  Vero cytotoxin produced by Escherichia coli strains of animal origin.

Authors:  M Kashiwazaki; T Ogawa; K Nakamura; Y Isayama; K Tamura; R Sakazaki
Journal:  Natl Inst Anim Health Q (Tokyo)       Date:  1981

3.  Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea.

Authors:  A D O'Brien; J W Newland; S F Miller; R K Holmes; H W Smith; S B Formal
Journal:  Science       Date:  1984-11-09       Impact factor: 47.728

4.  Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens and pigs.

Authors:  H W Smith; P Green; Z Parsell
Journal:  J Gen Microbiol       Date:  1983-10

5.  Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli.

Authors:  N A Strockbine; L R Marques; R K Holmes; A D O'Brien
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

6.  Vero response to a cytotoxin of Escherichia coli.

Authors:  J Konowalchuk; J I Speirs; S Stavric
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

7.  Isolation and characterization of Shigella shigae cytotoxin.

Authors:  S Olsnes; K Eiklid
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

8.  Hemorrhagic colitis associated with a rare Escherichia coli serotype.

Authors:  L W Riley; R S Remis; S D Helgerson; H B McGee; J G Wells; B R Davis; R J Hebert; E S Olcott; L M Johnson; N T Hargrett; P A Blake; M L Cohen
Journal:  N Engl J Med       Date:  1983-03-24       Impact factor: 91.245

9.  Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype.

Authors:  J G Wells; B R Davis; I K Wachsmuth; L W Riley; R S Remis; R Sokolow; G K Morris
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

10.  The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60 S ribosomal subunit.

Authors:  R Reisbig; S Olsnes; K Eiklid
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

View more
  217 in total

1.  Inhibition of neutrophil apoptosis by verotoxin 2 derived from Escherichia coli O157:H7.

Authors:  J Liu; T Akahoshi; T Sasahana; H Kitasato; R Namai; T Sasaki; M Inoue; H Kondo
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Sequence of Shiga toxin 2 phage 933W from Escherichia coli O157:H7: Shiga toxin as a phage late-gene product.

Authors:  G Plunkett; D J Rose; T J Durfee; F R Blattner
Journal:  J Bacteriol       Date:  1999-03       Impact factor: 3.490

3.  Apple flavonoid phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats.

Authors:  Jin-Hyung Lee; Sushil Chandra Regmi; Jung-Ae Kim; Moo Hwan Cho; Hyungdon Yun; Chang-Soo Lee; Jintae Lee
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

4.  Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide.

Authors:  T Waddell; A Cohen; C A Lingwood
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  Shigella dysenteriae type 1-specific bacteriophage from environmental waters in Bangladesh.

Authors:  Shah M Faruque; Nityananda Chowdhury; Rasel Khan; M Rubayet Hasan; Jebun Nahar; M Johirul Islam; Shinji Yamasaki; A N Ghosh; G Balakrish Nair; David A Sack
Journal:  Appl Environ Microbiol       Date:  2003-12       Impact factor: 4.792

6.  Genome analysis of a novel Shiga toxin 1 (Stx1)-converting phage which is closely related to Stx2-converting phages but not to other Stx1-converting phages.

Authors:  Toshio Sato; Takeshi Shimizu; Masahisa Watarai; Midori Kobayashi; Shigeyuki Kano; Takashi Hamabata; Yoshifumi Takeda; Shinji Yamasaki
Journal:  J Bacteriol       Date:  2003-07       Impact factor: 3.490

7.  Pancreatitis and E. coli O157:H7 colitis without hemolytic uremic syndrome.

Authors:  David A Sass; Kapil B Chopra; Miguel D Regueiro
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

8.  Genetic typing of shiga toxin 2 variants of Escherichia coli by PCR-restriction fragment length polymorphism analysis.

Authors:  Liesbet De Baets; Imme Van der Taelen; Marina De Filette; Denis Piérard; Lesley Allison; Henri De Greve; Jean-Pierre Hernalsteens; Hein Imberechts
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

9.  Clonal relationships among Escherichia coli strains that cause hemorrhagic colitis and infantile diarrhea.

Authors:  T S Whittam; M L Wolfe; I K Wachsmuth; F Orskov; I Orskov; R A Wilson
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

10.  Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice.

Authors:  J Fujii; T Kita; S Yoshida; T Takeda; H Kobayashi; N Tanaka; K Ohsato; Y Mizuguchi
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.